Skip to main content
. 2015 Jan 30;6(6):4239–4252. doi: 10.18632/oncotarget.2978

Figure 1. Clinical significance of WISP-1 and VEGF-A in specimens from patients with OSCC.

Figure 1

Tumor specimens were immunostained (IHC) with anti-WISP-1 and anti-VEGF-A antibodies. The staining intensity was scored 1–5. (A) IHC photographs. (E = epithelial, T = tumor, S = stroma). (B–D) Quantitative results and correlation between WISP-1, VEGF-A, and OSCC clinical grade.